Substantia Nigra (diagnostic imaging) < Substantia Nigra (drug effects) < Substantia Nigra (embryology)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]

Ident.	Authors (with country if any)	Title
000014 (1999)	A F Miranda [Canada] ; M A Sutton ; R J Beninger ; K. Jhamandas ; R J Boegman	Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.
000027 (1999)	G D Muir [Canada] ; I Q Whishaw	Ground reaction forces in locomoting hemi-parkinsonian rats: a definitive test for impairments and compensations.
000031 (1999)	M O Hebb [Canada] ; H A Robertson	Motor effects and mapping of cerebral alterations in animal models of Parkinson's and Huntington's diseases.
000095 (2000)	F. Calon [Canada] ; M. Morissette ; M. Goulet ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di Paolo	125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
000096 (2000)	I. Mendez [Canada] ; A. Dagher ; M. Hong ; A. Hebb ; P. Gaudet ; A. Law ; S. Weerasinghe ; D. King ; J. Desrosiers ; S. Darvesh ; T. Acorn ; H. Robertson	Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations.
000105 (2000)	J M Van Kampen [Canada] ; E G Mcgeer ; A J Stoessl	Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
000106 (2000)	S. Callier [Canada] ; M. Morissette ; M. Grandbois ; T. Di Paolo	Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
000168 (2001)	C. Zhang [Canada] ; J P Steiner ; G S Hamilton ; T P Hicks ; M O Poulter	Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.
000173 (2001)	G A Metz [Canada] ; T. Farr ; M. Ballermann ; I Q Whishaw	Chronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6-OHDA dopamine-depleted (hemi-Parkinson analogue) rats.
000174 (2001)	A H Rajput [Canada]	Levodopa prolongs life expectancy and is non-toxic to substantia nigra.
000183 (2001)	A H Rajput [Canada]	The protective role of levodopa in the human substantia nigra.
000273 (2003)	Patricia Vergara-Aragon ; Claudia L R. Gonzalez ; Ian Q. Whishaw	A novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation.
000305 (2003)	Stephen J. Crocker [Canada] ; Patrice D. Smith ; Vernice Jackson-Lewis ; Wiplore R. Lamba ; Shawn P. Hayley ; Erich Grimm ; Steve M. Callaghan ; Ruth S. Slack ; Edon Melloni ; Serge Przedborski ; George S. Robertson ; Hymie Anisman ; Zul Merali ; David S. Park	Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease.
000421 (2004)	Anthony E. Lang [Canada] ; Jose A. Obeso	Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough.
000456 (2004)	Ronald B. Postuma [Canada] ; Anthony E. Lang	Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
000533 (2005)	K Adam Baker [Canada] ; Ivar Mendez	Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain.
000565 (2005)	Gerlinde A. Metz [Canada] ; Arthur Tse ; Mark Ballermann ; Lori K. Smith ; Karim Fouad	The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
000596 (2006)	J. Miklossy [Canada] ; D D Doudet ; C. Schwab ; S. Yu ; E G Mcgeer ; P L Mcgeer	Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys.
000662 (1991)	W G Tatton [Canada] ; C E Greenwood	Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism.
000721 (2007)	Mojgan Hodaie [Canada] ; Joseph S. Neimat ; Andres M. Lozano	The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
000996 (2009)	I A Prescott [Canada] ; J O Dostrovsky ; E. Moro ; M. Hodaie ; A M Lozano ; W D Hutchison	Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Substantia Nigra (drug effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Substantia Nigra (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Substantia Nigra (drug effects)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022